BACKGROUND: Major impediments to development of vaccines and drugs for Plasmodium vivax malaria are the inability to culture this species and the extreme difficulty in undertaking clinical research by experimental infection. METHODS: A parasite bank was collected from a 49-year-old woman with P. vivax infection, characterized, and used in an experimental infection study. RESULTS: The donor made a full recovery from malaria after collection of a parasite bank, which tested negative for agents screened for in blood donations. DNA sequence analysis of the isolate indicated that it was clonal. Two subjects inoculated with the isolate became polymerase chain reaction positive on days 8 and 9, with onset of symptoms and positive blood smears on day 14, when they were treated with artemether-lumefantrine, with rapid clinical and parasitologic response. Transcripts of the parasite gene pvs25 that is expressed in gametocytes, the life cycle stage infectious to mosquitoes, were first detected on days 11 and 12. CONCLUSIONS: This experimental system results in in vivo parasite growth, probably infectious to mosquitoes. It offers the opportunity to undertake studies previously impossible in P. vivax that will facilitate a better understanding of the pathology of vivax malaria and development of antimalarial drugs and vaccines. Trial Registration. ANZCTR: 12612001096842.
BACKGROUND: Major impediments to development of vaccines and drugs for Plasmodium vivaxmalaria are the inability to culture this species and the extreme difficulty in undertaking clinical research by experimental infection. METHODS: A parasite bank was collected from a 49-year-old woman with P. vivax infection, characterized, and used in an experimental infection study. RESULTS: The donor made a full recovery from malaria after collection of a parasite bank, which tested negative for agents screened for in blood donations. DNA sequence analysis of the isolate indicated that it was clonal. Two subjects inoculated with the isolate became polymerase chain reaction positive on days 8 and 9, with onset of symptoms and positive blood smears on day 14, when they were treated with artemether-lumefantrine, with rapid clinical and parasitologic response. Transcripts of the parasite gene pvs25 that is expressed in gametocytes, the life cycle stage infectious to mosquitoes, were first detected on days 11 and 12. CONCLUSIONS: This experimental system results in in vivo parasite growth, probably infectious to mosquitoes. It offers the opportunity to undertake studies previously impossible in P. vivax that will facilitate a better understanding of the pathology of vivax malaria and development of antimalarial drugs and vaccines. Trial Registration. ANZCTR: 12612001096842.
Authors: James G Kublin; Fraction K Dzinjalamala; Deborah D Kamwendo; Elissa M Malkin; Joseph F Cortese; Lisa M Martino; Rabia A G Mukadam; Stephen J Rogerson; Andres G Lescano; Malcolm E Molyneux; Peter A Winstanley; Phillips Chimpeni; Terrie E Taylor; Christopher V Plowe Journal: J Infect Dis Date: 2002-01-17 Impact factor: 5.226
Authors: C M Trenholme; R L Williams; R E Desjardins; H Frischer; P E Carson; K H Rieckmann; C J Canfield Journal: Science Date: 1975-11-21 Impact factor: 47.728
Authors: Jianbing Mu; Michael T Ferdig; Xiaorong Feng; Deirdre A Joy; Junhui Duan; Tetsuya Furuya; G Subramanian; L Aravind; Roland A Cooper; John C Wootton; Momiao Xiong; Xin-zhuan Su Journal: Mol Microbiol Date: 2003-08 Impact factor: 3.501
Authors: Michele D Hastings; Kathryn M Porter; Jason D Maguire; Ika Susanti; Winni Kania; Michael J Bangs; Carol Hopkins Sibley; J Kevin Baird Journal: J Infect Dis Date: 2004-02-04 Impact factor: 5.226
Authors: Tonia Woodberry; Jessica R Loughland; Gabriela Minigo; Julie G Burel; Fiona H Amante; Kim A Piera; Yvette McNeil; Tsin W Yeo; Michael F Good; Denise L Doolan; Christian R Engwerda; James S McCarthy; Nicholas M Anstey Journal: Infect Immun Date: 2017-05-23 Impact factor: 3.441
Authors: Stephan Karl; Moses Laman; Brioni R Moore; John Benjamin; Tamarah Koleala; Clemencia Ibam; Bernadine Kasian; Peter M Siba; Andreea Waltmann; Ivo Mueller; Robert C Woodward; Timothy G St Pierre; Timothy M E Davis Journal: Antimicrob Agents Chemother Date: 2015-05-18 Impact factor: 5.191
Authors: Danielle I Stanisic; John Gerrard; James Fink; Paul M Griffin; Xue Q Liu; Lana Sundac; Silvana Sekuloski; Ingrid B Rodriguez; Jolien Pingnet; Yuedong Yang; Yaoqi Zhou; Katharine R Trenholme; Claire Y T Wang; Hazel Hackett; Jo-Anne A Chan; Christine Langer; Eric Hanssen; Stephen L Hoffman; James G Beeson; James S McCarthy; Michael F Good Journal: Infect Immun Date: 2016-08-19 Impact factor: 3.441
Authors: Nicholas M Anstey; Tsin W Yeo; Matthew J Grigg; Timothy William; Jayaram Menon; Prabakaran Dhanaraj; Bridget E Barber; Christopher S Wilkes; Lorenz von Seidlein; Giri S Rajahram; Cielo Pasay; James S McCarthy; Ric N Price Journal: Lancet Infect Dis Date: 2015-11-19 Impact factor: 25.071
Authors: Ruth O Payne; Kathryn H Milne; Sean C Elias; Nick J Edwards; Alexander D Douglas; Rebecca E Brown; Sarah E Silk; Sumi Biswas; Kazutoyo Miura; Rachel Roberts; Thomas W Rampling; Navin Venkatraman; Susanne H Hodgson; Geneviève M Labbé; Fenella D Halstead; Ian D Poulton; Fay L Nugent; Hans de Graaf; Priya Sukhtankar; Nicola C Williams; Christian F Ockenhouse; April K Kathcart; Aziz N Qabar; Norman C Waters; Lorraine A Soisson; Ashley J Birkett; Graham S Cooke; Saul N Faust; Colleen Woods; Karen Ivinson; James S McCarthy; Carter L Diggs; Johan Vekemans; Carole A Long; Adrian V S Hill; Alison M Lawrie; Sheetij Dutta; Simon J Draper Journal: J Infect Dis Date: 2016-02-04 Impact factor: 5.226